DXCM Covered Call Strategy: Is Now a Good Time to Sell Calls? Moderate ยท 70/100

DexCom Inc (Healthcare) ยท $79.32 ยท Analysis generated Nov 20, 2026 ยท Data as of market close Nov 20

Quick Take

DXCM is trading at $79.32 with RSI at 44 (neutral territory). Options IV is at 43% โ€” 59% below its 30-day average of 104%. Neither RSI nor IV strongly favor selling calls right now. Consider waiting for better conditions or using a different strategy.

Technical Signals

RSI (14)
44
IV Today
43.1%
IV vs 30d Avg
-59%
MACD
bullish
ADX
12
MFI
38

The Setup

DXCM Covered Call

LONG STOCK
100 shares @ $79.32
SHORT CALL
$86 Jan '27 ยท $3.15/sh
Net Cost
$7,617
Max Profit
+$983
Break-even
$76.17
Projected P&L at Target
+$950 (12.5%)
P&L at Expiry Now $79 $56 $79 $103

P&L Scenarios

What happens at different DXCM prices by expiry:

DXCM Price Today +3d (Nov 24) +7d (Nov 28) Dec 9 Dec 27 Jan 15 (exp)
$63 (-20%) -$1,293 -$1,290 -$1,286 -$1,278 -$1,271 -$1,271
$67 (-15%) -$927 -$921 -$914 -$896 -$877 -$875
$71 (-10%) -$583 -$574 -$562 -$531 -$489 -$478
$75 (-5%) -$273 -$260 -$244 -$197 -$121 -$82
$78 (-2%) -$104 -$90 -$71 -$15 +$83 +$156
$79 (0%) โ† now -$0 +$15 +$36 +$96 +$209 +$315
$81 (+2%) +$97 +$113 +$135 +$200 +$325 +$474
$83 (+5%) +$230 +$247 +$270 +$340 +$479 +$712
$86 (+8%) โ† target +$346 +$364 +$389 +$462 +$608 +$950
$87 (+10%) +$416 +$434 +$458 +$532 +$679 +$983
$91 (+15%) +$562 +$579 +$603 +$674 +$811 +$983
$95 (+20%) +$672 +$688 +$710 +$774 +$889 +$983

Why This Strategy, Why Now

  • RSI at 44
  • IV -59% vs avg โ€” premiums below average, less income
  • MACD bullish โ€” stock has upward momentum
  • ADX at 12 โ€” range-bound, perfect for selling calls
  • No squeeze โ€” no imminent breakout

Key Risks

DXCM has bullish momentum (MACD). If a positive catalyst emerges (earnings beat, product launch), the stock could gap past your strike. Consider rolling the call up if DXCM approaches the strike before expiry.